Intratympanic gentamicin for Ménière's disease; a survey of current UK practice

Journal of Laryngology and Otology

Volumn 117, Issue 6, 2003, Pages 459-461

  Obholzer, R J ^a   Wareing, M J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Aminoglycosides; M ni re's Disease

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; GENTISONE;

ARTICLE; AUDITORY TUBE; CATHETER; CLINICAL PRACTICE; DRUG DELIVERY SYSTEM; HUMAN; INJECTION; MENIERE DISEASE; NEEDLE; QUESTIONNAIRE; SURGEON; TYMPANOSTOMY TUBE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; CLINICAL PROTOCOLS; DRUG ADMINISTRATION ROUTES; GENTAMICINS; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; MENIERE'S DISEASE; PROFESSIONAL PRACTICE;

EID: 0037833450     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/002221503321892299     Document Type: Article

References (16)

1. Schuknecht H. Ablation therapy in Ménière's disease. Acta Otolaryngol (Stockh) 1957;132(suppl):1-42
2. Lange G. Die intratympanale Behandlung des Morbus Meniere mit ototoxishen Antibiotica. Laryngo-Rhino-Otol 1977;56:409-14
3. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997;18:520-6
4. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Ménière's disease. Am J Otol 1992;13:18-22
5. Blakley BW. Update on intratympanic gentamicin for Ménière's disease. Laryngoscope 2000;110:236-40
6. Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG. Intratympanic gentamicin instillation as treatment of unilateral Ménière's disease: update of an ongoing study. Am J Otol 1993;14:278-82
7. Wright T. Ototoxicity. In: Wright T, Ludman H (eds.): Diseases of the Ear. London: Arnold, 1997,504-15
8. Fischel-Ghodsian N, Prezant TR, Chaltraw WE, Wendt KA, Nelson RA, Arnos KS, et al. Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity. Am J Otol 1997;18:173-8
9. Longridge NS, Mallinson AI. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease. J Otol 2000;29:35-9
10. Minor LB. Intratympanic gentamicin for control of vertigo in Ménière's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19
11. Kaasinen S, Pyykko I, Ishizaki H, Aalto H. Intratympanic gentamicin in Ménière's disease. Acta Otolaryngol Head Neck Surg 1998;118:294-8
12. McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ. Intratympanic gentamicin treatment for Ménière's disease. Otolaryngol Head Neck Surg 1998;118:589-96
13. Pfleiderer AG. The current role of local intratympanic gentamicin therapy in the management of unilateral Ménière's disease. Clin Otolaryngol 1998;23:34-41
14. Corsten M, Marsan J, Schramm D, Robichaud J. Treatment of intractable Ménière's disease with intratympanic gentamicin: review of the university of Ottowa experience. J Otolaryngol 1997;26:361-4
15. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Ménière's disease: a preliminary report. Laryngoscope 1997;107:49-55
16. Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG, Beatty CW. Low dose intratympanic gentamicin and the treatment of Ménière's disease: preliminary results. Laryngoscope 1997;107:83-9